Clinical Trial Update: Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hypofractionated radiation therapy after mastectomy to prevent recurrence in stage IIa-IIIa breast cancer has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Ductal Breast Carcinoma, Invasive Breast Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-24